Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Plos One
|
August 29, 2024
Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model
Claire So Jeong Lee, Pedro Mateu-Gelabert, Yesenia Aponte Melendez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 15, 2014
Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239
Kristen M Marks, Douglas Kitch, Raymond T Chung, et al.
Drug and Alcohol Dependence Reports
|
January 16, 2023
Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial
Shashi N Kapadia, Benjamin J Eckhardt, Jared A Leff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 25, 2012
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection
Daniel S Fierer, Douglas T Dieterich, M Isabel Fiel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 26, 2025
Hepatitis B Vaccination Histories in Persons with HIV Needing Revaccination
Minhee Kang, Triin Umbleja, Anchalee Avihingsanon, et al.
Plos One
|
July 16, 2020
Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing
Hui Li, Kristen M Marks, Andrew H Talal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 5, 2023
Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus
Kristen M Marks, Minhee Kang, Triin Umbleja, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 23, 2017
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C
Susanna Naggie, Kristen M Marks, Michael Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 21, 2019
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals
Susanna Naggie, Daniel S Fierer, Michael D Hughes, et al.
JAMA
|
July 2, 2025
HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine: The BEe-HIVe Trial End-of-Study Results
Kristen M Marks, Minhee Kang, Triin Umbleja, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Plos One
|
August 29, 2024
Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model
Claire So Jeong Lee, Pedro Mateu-Gelabert, Yesenia Aponte Melendez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 15, 2014
Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239
Kristen M Marks, Douglas Kitch, Raymond T Chung, et al.
Drug and Alcohol Dependence Reports
|
January 16, 2023
Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial
Shashi N Kapadia, Benjamin J Eckhardt, Jared A Leff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 25, 2012
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection
Daniel S Fierer, Douglas T Dieterich, M Isabel Fiel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 26, 2025
Hepatitis B Vaccination Histories in Persons with HIV Needing Revaccination
Minhee Kang, Triin Umbleja, Anchalee Avihingsanon, et al.
Plos One
|
July 16, 2020
Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing
Hui Li, Kristen M Marks, Andrew H Talal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 5, 2023
Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus
Kristen M Marks, Minhee Kang, Triin Umbleja, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 23, 2017
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C
Susanna Naggie, Kristen M Marks, Michael Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 21, 2019
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals
Susanna Naggie, Daniel S Fierer, Michael D Hughes, et al.
JAMA
|
July 2, 2025
HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine: The BEe-HIVe Trial End-of-Study Results
Kristen M Marks, Minhee Kang, Triin Umbleja, et al.
Page
of 4